arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Caris Life Sciences, Inc.

CAI Health Care Medical Specialities
$31.71
▲ +1.9% Today
as of Oct 22, 16:47 ET
Last 30 days +21.73% Sep 14 → Oct 22
$25.55 $27.37 $29.20 $31.03 $32.85 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$32.00
High
$32.61
Low
$30.33
Volume
$2M
Avg Vol
$3M
Mkt Cap
$7.7B
P/E (TTM)
—
Beta
—
52w High
$33.13
52w Low
$14.19
Div Yield
—
Shares Out
$283M

Recent Press Releases & News last 60 days · 16 items

Oct 19 · 10:30 PR PR Newswire
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
Oct 15 · 12:30 PR PR Newswire
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Oct 14 · 12:30 PR PR Newswire
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
▸ Show all 16 press releases & news Free account →

CAI earnings at a glance

Caris Life Sciences, Inc. (CAI) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of $0.03, compared with $0.08 in the same quarter last year (-62%). The options market is pricing a move of about ±20.5% after the report, a range of roughly $25.20 to $38.22 from today's $31.71. Over its last 5 reports the stock rose the next day 3 times and fell 2, moving ±13.2% on average; after the most recent report on Aug 5, 2026 it moved +21.6%. That means options currently expect more movement than CAI has typically delivered. CAI beat the consensus EPS estimate in 4 of its last 5 reported quarters. Implied volatility is currently 174%. The share price of $31.71 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$14
$33
93% of range
Avg surprise (last 5)
+588.6%
Avg reaction (last 5)
-0.5%
60% positive
Latest IV / EM
174%
EM ±20.5% · $25 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.57$-2.61$-1.65$-0.68$0.28 Actual $-2.54Actual $-2.59Actual $-3.57Actual $-0.54Est $-0.21Actual $0.08Est $-0.08Actual $0.28Est $0.01Est $-0.02Est $-0.01 JunSepMarJun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-103M$-8M$87M$182M$277M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 5, 2026Jun/2026 — $-0.01 +100.0% +98.2% +21.6% earnings
Thu May 7, 2026Mar/2026 — $-0.02 +100.0% — -18.6% earnings
Thu Feb 26, 20268K 2026-02-26 $0.28 $0.01 +2,700% — +4.7% earnings
Wed Nov 5, 2025Sep/2025 $0.08 $-0.08 +200.0% — -15.7% earnings
Tue Aug 12, 2025Jun/2025 $-0.54 $-0.21 -157.1% — +5.6% earnings
Mon Mar 31, 2025Mar 2025 $-3.57 — — — — financials
Mon Sep 30, 2024Sep 2024 $-2.59 — — — — financials
Sun Jun 30, 2024Jun 2024 $-2.54 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER $0.03$0.08 -62.5%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$264M$216M—$217M$181M$121M—$102M
Cost of revenue————————
Gross profit————————
Operating income$27M$5M—$33M$-18M$-58M—$-61M
Net income$-637,000$-510,000—$24M$-72M$-103M—$-68M
EPS (diluted)———$0.08$-7.97$-3.57—$-2.59

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents—$820M—$753M$719M$31M$64M—
Inventory————————
Total current assets$1.06B$1.01B$998M$854M$833M—$216M—
Total assets$1.23B$1.16B$1.13B$985M$955M—$344M—
Long-term debt$393M$381M$379M$376M$374M—$319M—
Total liabilities$638M$569M$548M$506M$502M—$621M—
Total equity$592M$593M$577M$478M$453M$-2.60B$-2.50B$-2.44B

Implied volatility — last 90 days

59%137%214%292%370% Jun 07 — IV 112% · EM ±15.5%Jun 08 — IV 105% · EM ±13.9%Jun 09 — IV 146% · EM ±18.3%Jun 10 — IV 130% · EM ±15.3%Jun 11 — IV 83% · EM ±9.2%Jun 12 — IV 112% · EM ±11.4%Jun 15 — IV 91% · EM ±6.6%Jun 16 — IV 174% · EM ±10.3%Jun 17 — IV 127% · EM ±5.3%Jun 19 — IV 86% · EM ±19.1%Jun 22 — IV 72% · EM ±15.0%Jun 23 — IV 91% · EM ±18.6%Jun 24 — IV 73% · EM ±14.7%Jun 25 — IV 130% · EM ±25.4%Jun 26 — IV 76% · EM ±14.6%Jun 29 — IV 85% · EM ±15.1%Jun 30 — IV 110% · EM ±18.9%Jul 01 — IV 109% · EM ±18.3%Jul 02 — IV 106% · EM ±17.2%Jul 03 — IV 110% · EM ±17.2%Jul 06 — IV 85% · EM ±11.8%Jul 07 — IV 111% · EM ±14.7%Jul 08 — IV 92% · EM ±11.5%Jul 09 — IV 114% · EM ±13.4%Jul 10 — IV 138% · EM ±15.3%Jul 13 — IV 132% · EM ±11.0%Jul 14 — IV 253% · EM ±18.3%Jul 15 — IV 252% · EM ±14.9%Jul 16 — IV 370% · EM ±15.5%Jul 20 — IV 81% · EM ±19.1%Jul 21 — IV 78% · EM ±18.1%Jul 22 — IV 85% · EM ±19.5%Jul 23 — IV 114% · EM ±25.6%Jul 24 — IV 81% · EM ±18.0%Jul 27 — IV 116% · EM ±24.3%Jul 28 — IV 65% · EM ±13.3%Jul 29 — IV 88% · EM ±17.6%Jul 30 — IV 171% · EM ±33.5%Jul 31 — IV 88% · EM ±16.8%Aug 03 — IV 124% · EM ±21.9%Aug 04 — IV 103% · EM ±17.7%Aug 05 — IV 137% · EM ±22.9%Aug 06 — IV 96% · EM ±15.5%Aug 07 — IV 72% · EM ±11.2%Aug 10 — IV 145% · EM ±20.1%Aug 11 — IV 95% · EM ±12.5%Aug 12 — IV 99% · EM ±12.4%Aug 14 — IV 102% · EM ±11.2%Aug 17 — IV 129% · EM ±10.7%Aug 18 — IV 80% · EM ±5.8%Aug 19 — IV 110% · EM ±6.5%Aug 24 — IV 71% · EM ±14.9%Aug 25 — IV 67% · EM ±13.8%Aug 26 — IV 120% · EM ±24.1%Aug 27 — IV 115% · EM ±22.5%Aug 28 — IV 78% · EM ±15.0%Aug 31 — IV 64% · EM ±11.4%Sep 01 — IV 74% · EM ±12.8%Sep 02 — IV 110% · EM ±18.3%Sep 03 — IV 100% · EM ±16.2%Sep 04 — IV 94% · EM ±14.7%Sep 07 — IV 106% · EM ±14.7%Sep 08 — IV 89% · EM ±11.8%Sep 09 — IV 125% · EM ±15.6%Sep 10 — IV 121% · EM ±14.4%Sep 11 — IV 99% · EM ±10.9%Sep 14 — IV 143% · EM ±11.9%Sep 15 — IV 104% · EM ±7.5%Sep 16 — IV 132% · EM ±7.8%Sep 17 — IV 180% · EM ±7.5%Sep 21 — IV 64% · EM ±13.3%Sep 22 — IV 59% · EM ±12.2%Sep 23 — IV 69% · EM ±13.8%Sep 24 — IV 87% · EM ±17.0%Sep 25 — IV 97% · EM ±18.6%Sep 28 — IV 64% · EM ±11.3%Sep 29 — IV 99% · EM ±17.1%Sep 30 — IV 99% · EM ±16.5%Oct 01 — IV 83% · EM ±13.5%Oct 02 — IV 77% · EM ±12.1%Oct 05 — IV 123% · EM ±17.0%Oct 06 — IV 100% · EM ±13.2%Oct 07 — IV 88% · EM ±11.1%Oct 08 — IV 174% · EM ±20.5%

Sector peers

BLLN
BillionToOne, Inc.
$6.3B $105.68+2.1%
HSIC
Henry Schein, Inc.
$9.3B $86.00+1.6%
GRAL
GRAIL, Inc.
$5.9B $127.06+1.9%
RDNT
RadNet, Inc.
$5.3B $70.26+0.9%
OSCR
Oscar Health, Inc.
$10.2B $33.32-1.0%
MOH
Molina Healthcare Inc
$10.2B $216.64-1.4%

CAI earnings FAQ

When is CAI's next earnings date?

Caris Life Sciences, Inc. is expected to report on November 4, 2026.

What is CAI's expected move for earnings?

Options currently price a move of about ±20.5%, or $6.51 per share either way from $31.71.

How does CAI stock usually react to earnings?

Across the last 5 reports the average next-day move was ±13.2%, up 3 times and down 2 times.

What EPS are analysts expecting from Caris Life Sciences, Inc.?

The consensus estimate is $0.03 per share, versus $0.08 a year ago.

What is CAI's implied volatility?

CAI's at-the-money implied volatility is about 174% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in